Javeri Fiscal Services Ltd.

About Javeri

Equity

Derivatives

Mutual Funds

IPO

Corporate Info

Research

Corporate Info

Smart Quotes

Company Background

Board of Directors

Balance Sheet

Profit & Loss

Peer Comparison

Cash Flow

Shareholdings Pattern

Quarterly Results

Share Price

Deliverable Volume

Historical Volume

MF Holdings

Financial Ratios

Directors Report

Price Charts

Beta Analysis

Board Meetings

Corporate Announcements

Book Closure

Bonus

Company News

Dividend Details

Bulk Deals

Insider Trading

Advanced Chart

HOME > CORPORATE INFO > SMART QUOTES

Smart Quotes

Dr. Reddy's Laboratories Ltd.

Industry : Pharmaceuticals & Drugs

BSE Code	500124
ISIN Demat	INE089A01031
Book Value	345.76

NSE Code	DRREDDY
Dividend Yield %	0.61
Market Cap	1101647.94

P/E	20.59
EPS	64.10
Face Value	1


	BSE		NSE

26-Jun-2025 12:14

Last Price	1317.00
Net Change	-23.85
% Change	-1.78%
Prev.Close	1340.85
Open	1327.95
High	1332.60
Low	1315.00
Volume	23322

Last Price	1316.50
Net Change	-25.1
% Change	-1.87%
Prev.Close	1341.60
Open	1326.00
High	1333.70
Low	1314.60
Volume	844479

Value	30715074
Best Buy	1316.05
Best Sell	1316.90
Best Quantity	10
Sell Quantity	9
Today's Range	1332.60
52-Week High	1420.20
52-Week Low	1025.90

Value	1111756603.5
Best Buy	1316.50
Best Sell	1316.60
Best Quantity	97
Sell Quantity	5
Today's Range	1333.70
52-Week High	1421.49
52-Week Low	1020.00

Open Price	1326.00
High Price	1332.40
Low Price	1314.10
Last Price	1317.00
Prev Close	1341.20
Change	-24.20
% Change	-1.80 %

Average Price	1320.83
Underlying Value	1316.50
Number of contracts traded	2806
Turnover in Rs. Lakhs	23164
Open Interest	3083125.00
Change in O I	-368750.00
% Change in O I	-10.68 %

Today

You need to upgrade your Flash Player

Best Bid

Best Offer

Quantity	10
Price	1316.05

Quantity	9
Price	1316.90

Best Bid

Best Offer

Quantity	97
Price	1316.50

Quantity	5
Price	1316.60

Best Bid

Best Offer

Quantity	2500
Price	1316.3

Quantity	625
Price	1316.9

Holding Details

Latest Corporate Events

Bonus

1 : 1

28-Aug-06

Book Closure

17-Jul-24

19-Jul-24

Dividend

800 %

10-Jul-25

Company News

05-06-2025

Dr. Reddy's Laboratories,...

05-06-2025

Dr. Reddy’s Laboratories...

05-06-2025

Dr. Reddy's Laboratories ...

26-05-2025

USFDA completes GMP inspe...

17-05-2025

USFDA completes GMP inspe...

17-05-2025

Dr Reddys Laboratories in...

10-05-2025

Dr. Reddy’s Laboratories ...

Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
On an average, loss makers registered net trading loss close to ₹ 50,000.
Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source: Click Here.